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The Plenty of SH3 domains protein (POSH) is an E3 ligase and a scaffold in the JNK mediated apop-
tosis, linking Rac1 to downstream components.
We here describe POSH2 which was identiﬁed from a p21-activated kinase 2 (PAK2) interactor
screen. POSH2 is highly homologous with other members of the POSH family; it contains four Src
homology 3 (SH3) domains and a RING ﬁnger domain which confers E3 ligase activity to the protein.
In addition POSH2 contains an N-terminal extension which is conserved among its mammalian
counterparts. POSH2 interacts with GTP-loaded Rac1. We have mapped this interaction to a previ-
ously unrecognized partial Cdc42/Rac1-interactive binding domain.
Structured summary:
MINT-7987761: POSH1 (uniprotkb:Q9HAM2) physically interacts (MI:0915) with Ubiquitin (uni-
protkb:P62988) by anti tag coimmunoprecipitation (MI:0007)
MINT-7987932: PAK2 (uniprotkb:Q13177) binds (MI:0407) to CDC42 (uniprotkb:Q07912) by solid phase
assay (MI:0892)
MINT-7987908: POSH1 (uniprotkb:Q9HAM2) binds (MI:0407) to Rac1 (uniprotkb:P63000) by solid phase
assay (MI:0892)
MINT-7987880: POSH2 (uniprotkb:Q8TEJ3) binds (MI:0407) to Rac1 (uniprotkb:P63000) by solid phase
assay (MI:0892)
MINT-7987734: POSH2 (uniprotkb:Q8TEJ3) physically interacts (MI:0915) with Ubiquitin (uni-
protkb:P62988) by anti tag coimmunoprecipitation (MI:0007)
MINT-7987779, MINT-7987804, MINT-7987824, MINT-7987838, MINT-7987853: Rac1 (uni-
protkb:P63000) physically interacts (MI:0915) with POSH2 (uniprotkb:Q8TEJ3) by anti tag coimmunopre-
cipitation (MI:0007)
MINT-7987920: PAK2 (uniprotkb:Q13177) binds (MI:0407) to Rac1 (uniprotkb:P63000) by solid phase
assay (MI:0892)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Protein–protein interactions domains play important roles in
many cellular processes. To perform their proper functions, pro-
teins have to be directed to speciﬁc cellular structures and loca-
tions and have to be connected to different interaction partners.chemical Societies. Published by E
, p21-activated kinase; CRIB,
l Technology, University of
+358 3 3551 7332.
ema).One common interaction domain is the Src homology 3 (SH3)
domain [1,2]. The human genome contains about 217 SH3-domain
containing proteins with in total almost 300 different SH3 domains
[3].
The ligand of SH3 domains is the so called left-handed polypro-
line (PPII) helix which is a short peptide, usually containing several
proline residues and referred to as the PxxP-motif (reviewed in
[4]).
The p21-activated kinases (PAKs) are serine–threonine kinases
involved in many cellular processes (reviewed in [5]). Major roles
have been studied in cytoskeletal rearrangements [6], immunol-
ogy and viral pathology [7], and the p21-activated kinases are
studied as targets for cancer therapy [8,9]. The activity of theselsevier B.V. All rights reserved.
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by which the catalytic cleft of the kinase domain is occupied by
part of the N-terminal regulatory domain in a trans manner.
The N-terminal domain has two functions. It serves as an inhibi-
tor of the kinase domain, but it also contains several sites for
interactions with other proteins, such as the Cdc42/Rac-interac-
tive binding (CRIB) motif for the interaction with the small
PAK-activating GTPases Cdc42 and Rac, but also several PxxP-mo-
tifs are found [5].
In a screen of all SH3 domains present in the human proteome
for p21-activated kinase interacting SH3-domain containing pro-
teins we identiﬁed the third SH3 domain of a protein we called
POSH2 [3]. POSH2, like Plenty of SH3 domains (POSH, [11]) con-
tains four SH3 domains, as well as a RING (Really Interesting
New Gene) ﬁnger domain. More recently, Wilhelm et al. identiﬁed
and cloned a similar protein from rat by BLAST homology searches
using the POSH sequence and named this protein POSH2 [12].
However this protein is not the ortholog of the human POSH2 we
identiﬁed and should therefore not have been named the same.
For clarity we will refer to the Wilhelm et al. protein as POSH3,
the original POSH identiﬁed by Tapon et al. [11] we will hereafter
refer to as POSH1.
POSH1 is the most studied member of this protein family so far.
POSH1 was originally identiﬁed as a novel Rac1 binding protein
from a yeast two-hybrid screen, containing a novel GTPase interac-
tion domain [11]. The N-terminal RING ﬁnger domain confers E3
ubiquitin ligase activity to the protein [13] and the four SH3-do-
main are critical for interactions with other proteins. In mamma-
lian cells POSH1 was found to function as a scaffold in a
multiprotein complex that links activated Rac1 and downstream
elements of the JNK apoptotic cascade [13].
In this paper we explore some of the characteristics of POSH2.
POSH2 was found to have a conserved N-terminal extension not
present in POSH1 and POSH3. We show that POSH2 has GTP-
loaded Rac1 binding activity and we have mapped this activity to
a partial CRIB domain.2. Materials and methods
2.1. Plasmids
The POSH2 fragments, POSH2 (amino acids (AA) 1–70) and
POSH2 (AA46–70) were cloned into pEGFP-N1 vector (Clontech)
50 of green ﬂuorescent protein (GFP) with their natural Kozak using
upstream primers 18 nucleotides 50 of the ATG.
The minimal Rac-binding site of POSH1 (AA292–362) [11] and
the same region from POSH2 (AA369–439) were cloned in frame
with Glutation-S-transferase (GST) into pEBG vector. Mutations
in pEBG-POSH2 (AA369–439) were generated using overlap PCR
and mutagenic oligo’s, yielding the mutants I403N/S404P/P406A
(ISP), I403N, S404P, L385A, and P414 (amino acid numbers accord-
ing to the full length sequence).
The N-terminus of PAK2 (PAK2N) (amino acids 1–251) was
cloned into bacterial expression pGEX 4T-1 vector (GE Healthcare).
Cdc42 and Rac1 were cloned into pGEX-PP containing an N-ter-
minal biotin puriﬁcation tag (BPT) [14]. The constitutively GTP-
loaded Rac1V12 was cloned into pEBB with an N-terminal Myc-
epitope tag.
pMT-123-Ubi-HA (Ubi-HA) was kindly provided by Daniela
Ungureanu, Tampere. Full length POSH1 (NCBI Genbank reference
sequence NM_020870) and POSH2 were cloned into pEBB vector
containing N-terminal Flag tag. The ring domain mutations, CH-
AA (POSH1 C28A/H30A, POSH2 C73A/H75A) and the CRIB domain
mutant (S404P), were made by overlap PCR using mutagenic
primers.The 3xAP-1-luc reporter construct was kindly provided by Kalle
Saksela, University of Helsinki.
2.2. Antibodies
The following antibodies were used: mouse anti-c-myc (Roche),
mouse anti-Flag M2 (Sigma), mouse anti-HA (Nordic BioSite AB),
mouse anti-GFP (Zymed), goat anti-GST (Amersham Biosciences).
Secondary antibodies used: biotinylated polyclonal goat anti-
mouse and biotinylated polyclonal rabbit anti-goat (both from
DakoCytomation).
2.3. Cell culture and mammalian cell transfections
HEK293T cells (ATCC) and osteosarcoma U2OS cells (kind gift
from Pekka Lappalainen, Helsinki) were cultured using standard
procedures in Dulbecco´s modiﬁed Eagle´s medium (DMEM; Lonza)
supplemented with 10% fetal calf serum (FCS; Sigma), 2 mM L-Ala-
nyl-L-Glutamine (Biochrom), 1% penicillin–streptomycin (Sigma–
Aldrich) at 37 C with 5% CO2. HEK293T cells were transfected
using TurboFect reagent (Fermentas) or by Ca-phosphate precipita-
tion [15] in the case of recombinant protein production for the
overlay assays. For immunoﬂuorescent assays U2OS cells were
grown on cover slips and transfections were performed using Tran-
sIT-LT1 transfection reagent (Mirus) according to the manufac-
turer’s instructions.
Cell lysates were made as described before [16]. Transfection
efﬁciency was monitored by determining beta-galactosidase activ-
ity from a co-transfected pEBB-LacZ plasmid using an o-nitro-
phenyl-b-D-galactopyranoside assay [17].
2.4. Immunoprecipitation and immunoblotting
For the ubiquitination assays and Rac co-immunoprecipitation
experiments Protein A-Sepharose CL-4B beads (GE Healthcare)
were incubated with antibodies (anti-Flag or anti-Myc, respec-
tively) and cell extracts (350 or 700 lg protein, respectively) for
3 h at 4 C. After washing three times with lysis buffer the beads
were boiled in sample buffer followed by SDS–PAGE. Proteins were
transferred to nitrocellulose membrane (Perkin–Elmer Life Sci-
ences) and analyzed by western blotting. Detection of the biotinyl-
ated secondary antibodies was done with streptavidin–
biotinylated horseradish peroxidase (SA-HRP) (GE Healthcare)
and enhanced chemiluminescence (ECL, Millipore). The quantita-
tive data was produced using Bio-Rad Quantity One Software ver-
sion 4.5.2.
2.5. Expression and puriﬁcation of recombinant proteins
Recombinant GST and GST-fusion proteins were produced
either in Escherichia coli bacteria (GST, GST-PAK2N, GST-BPT-
Cdc42, and GST-BPT-Rac1) or in HEK293T cells (GST-POSH1
(AA292–362) and GST-POSH2 (AA369–439)). Bacterial protein pro-
duction was induced with1 mM isopropyl b-D-1-thiogalactopyra-
noside (4 h). Cells were lysed in PBS/1% Triton X-100 and
complete protease inhibitor cocktail using sonication. Transfected
HEK293T cells were lysed 48 h after transfection. Cleared lysates
were incubated with Glutathione Sepharose 4B beads (GE Health-
care). After washing (1 PBS/1% Triton X-100, 2 PBS/0.1% Triton
X-100, 1 PBS), proteins were eluted (100 mM Tris (pH 9.8)/
20 mM glutathione) and dialyzed against PBS (4 C over night) or
concentrated in PBS by Amicon Ultra-4 centrifugal ﬁlter columns
(Millipore). Protein concentration was assayed using the DC Pro-
tein Assay (Bio-Rad) and the integrity of the puriﬁed proteins
was checked on SDS–PAGE gels using Coomassie blue.
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Adaptated from Tapon et al. [11]. 20 lg of GST, GST-POSH1
(AA292–362), and GST-POSH2 (AA369–439) and 2.5 lg of GST-
PAK2N were spotted on nitrocellulose strips. The strips were air-
dried and blocked (4 C over night) in 1 M glycine/5% milk pow-
der/5% fetal calf serum. 4 lg puriﬁed GST-BPT-Cdc42 or GST-BPT-
Rac1 were loaded with nucleotide in 50 ll 25 mM Tris (pH 7.4)/
0.1 M NaCl/5 mM EDTA/1 mM dithiotreitol including 0.2 mM gua-
nosine 50-O-(3-thiophosphate) tetralithium salt or guanosine 50-
diphosphate sodium salt (Sigma–Aldrich) (10 min, 30 C) and
stopped by the addition of MgCl2 up to 6 mM. The loaded GTPases
were then labeled (on ice, 15 min) with 2 ll SA-HRP. The blocked
strips were washed in buffer A (50 mM Tris (pH 7.5)/100 mM
NaCl/5 mM MgCl2/0.1 mM dithiothreitol and incubated (30 min,
4 C) with the indicated nucleotide loaded GTPases. The strips were
washed three times for 5 min with 3 ml of cold buffer A/0.1%
Tween. Biotin-labelled GTPases bound to the membrane were visu-
alized by ECL.
2.7. Luciferase reporter assay
Plasmids for full length POSH2, both wild type and S404P mu-
tant, were transfected to 293HEK cells together with an AP-1
report construct (3xAP-1-luc, containing three binding sites for
AP-1) and the lacZ transfection control plasmid in a 24 wells for-
mat. Two days after transfection, the cells were lysed in 150 ll
Luciferase Cell Culture Lysis Reagent (Promega). Lysates were
cleared by centrifugation (5 min 13,000g) and parts of the lysates
were used for beta-galactosidase assays and luciferase assays using
Luciferase Assay Reagent (Promega). Luciferase measures were
corrected over the transfection efﬁciency. Signiﬁcance of the data
was calculated using a Student t-test.3. Results and discussion
3.1. The POSH family has three mammalian members
We have cloned the full length coding sequence for the human
POSH2. The POSH2 cDNA encodes for a protein of 882 amino acids
which has a vast degree of homology to POSH1 (46% identity) and
POSH3 (33% identity). An alignment of the human andmouse or rat
POSH1–3 can be found in the Supplementary material as well as
cloning details. Extensive database searches using the CDART and
BLAST searches from NCBI have not revealed more members of this
protein family.
POSH2 contains the hallmark Cys3HisCys4 residues of the RING
ﬁnger domain that is also found in POSH1 and POSH3. Between the
second and the third SH3 domain there is a conserved region in all
POSH members. Part of this region in POSH1 (amino acids 292–
362) has previously been found to contain a minimal Rac-binding
site [11]. The SH3 domains, comprising a major part of the POSH
proteins, establish interactions with PxxP-motif containing pro-
teins. POSH1 and POSH2 both contain 4 SH3 domains but POSH3
lacks the 4th SH3 domain [12], likely having an effect on the panel
of interacting proteins.
POSH2 is highly conserved in mammals, but a POSH2 like se-
quence was also found from Gallus gallus (hypothetical protein
XP_416930) although the N-terminus of this protein is either dif-
ferent or not correctly predicted from the genomic sequence.
Microarray expression data of the human POSH2 is available from
the Weizmann Institute of Science GeneNote service, and shows
POSH2 expression in thymus, bone marrow, spleen, brain, spinal
cord, heart, skeletal muscle, kidney, lung, liver, pancreas, and pros-
tate. The currently available expression patterns for the POSH pro-teins are not directly comparable due to the different tissues
studied [11,12], but in general these proteins can be considered
as ubiquitously expressed. Detailed comparison of expression pat-
ters and interaction partners would be of interest since at this mo-
ment no data is available on possible functional redundancy of the
different POSH proteins.
In a recent paper by Votteler et al. [18] the authors found that
ALIX-mediated release of infectious HIV virions was enhanced by
POSH1 although silencing of POSH1 by RNAi did not have the
anticipated opposing effect. In the light of the presence of three
POSH proteins in mammalian cells it is however possible that
knockdown of all POSH family members would give the expected
results.
It is relevant to note that according to our database searches,
Drosophila melanogaster and other insects have only one POSH
gene.
3.2. POSH2 from different species contains an N-terminal extension
Surprisingly POSH2, in contrast to POSH1 and POSH3, has no in
frame stop codon 50 to the conserved methionine that precedes the
RING ﬁnger domain, however, there is an in frame start codon. The
sequences surrounding either ATG codon are not perfect Kozak
consensus sequences for translational start (Fig. 1B) so the start
of the protein coding sequence is not immediately apparent. BLAST
searches showed that the in frame upstream start codon is present
in POSH2 sequences from different species and the translated ami-
no acid sequence is conserved although the length of the extension
varies from 46 amino acids in humans to 28 amino acids in Bos
Taurus (Fig. 1A).
In order to determine which one is the preferred ATG for protein
translation in the POSH2 protein we made expression plasmids
encoding GFP preceded with and N-terminal fragment of POSH2
starting either from the ﬁrst or from the second ATG. Both con-
structs contain the natural Kozak sequence as is found from the
mRNA. As is shown in Fig. 1C, the construct starting from the sec-
ond ATG (ATG2) produces a protein of the expected molecular
weight, although a small amount of only GFP was detected in this
lane probably due to proteolytic cleavage. The construct that starts
from the ﬁrst ATG, and therefore contains both ATGs (ATG1+2),
produced the longer protein (AA1–70) GFP as well as small
amounts of the (AA46–70) GFP. Quantiﬁcation of the expression
levels from six different experiments showed a ration of 63:37 of
the usage of the ﬁrst ATG over the second ATG. We therefore con-
cluded that the ﬁrst ATG is a bona ﬁde start site for protein trans-
lation, but signiﬁcant usage of the second site was also observed.
The possible function for the N-terminal extension of POSH2 to
act as an N-terminal targeting sequence was excluded (see Supple-
mentary data).
3.3. POSH2 has ubiquitin ligase activity
The RING ﬁnger domain of POSH1 was found to transfer E3 li-
gase activity to the protein [13]. Like POSH1, POSH2 contains all
the characteristic amino acids of the RING ﬁnger motif. We there-
fore decided to mutate two of the critical amino acids to study the
possible E3 ligase activity of POSH2. The wild type and mutant con-
structs were transfected to 293 HEK cells in the absence or pres-
ence of co-transfected Ubi-HA plasmid. Transfection efﬁciencies
were monitored by determining beta-galactosidase activity from
a co-transfected pEBB-LacZ plasmid using a colorimetric assay.
However, this is also a measure for the survival of the transfected
cells. As shown in Fig. 2, we found that in the case of transfection
of the wild type POSH1 or POSH2 together with the Ubi-HA plas-
mid resulted in a marked reduction of the expression of beta-
galactosidase suggesting that under these conditions there is a
10 20 30 40 50 60
H. sapiens
P. troglodytes
M. domestica
M. musculus
R. norvegicus
B. taurus
M L L G A SWL C A S K A A A A A AQ S EGD ED R PG ER R R R R A A AT A AG A - - - G ED MD E S S L L D L L EC S
M L L G A SWL C A S K A A A A A AQ S EGD ED R PG ER R R R R A A AT A AG A - - - G ED MD E S S L L D L L EC S
M L L G A SWL C A S K - - A A A AQ S EG E E ER QG ER R R R R A A A A A A A A A AGG E EMD E S S L L D L L EC S
M L L G A SWL C A S K A A AT A AR G EG E - D R QG EQQR G AQ AR T - - - - - - - E ED MD E S S L L D L L EC S
M L L G A SWL C A S K A A AT A A PG EGD - D R QG EQQR GD Q AR T - - - - - - - E ED MD E S S L L D L L EC S
M L L G A PR L C A SR A A A A AQR ED D G - D R L G - - - - G - - - - - - - - - - - - - - D MD E S S L L D L L EC S
POSH2-ATG1 T C C C C C A T GC T G
POSH2-ATG2 G A G G A C A T GG A C
POSH1 A T A A A GA T GG A T
C C C C A T GGGA/
B
A
C
G
AT
G
1+
2
AT
G
2
co
nt
ro
l
-  (AA1-70)-GFP
-  (AA46-70)-GFP
-  GFP
33 -
28 -
Fig. 1. POSH2 contains a conserved N-terminal extension. (Panel A) Alignment of the (predicted) amino acid sequences of the N-terminal extension of POSH2 proteins from
different species. Shading of amino acids is as follows: dark grey; identical in 5 or more sequences, middle grey; identical in 4 sequences, light grey; identical in three
sequences. Both methionine residues are indicated with arrows. (Panel B) Alignment of both POSH2 ATG start codons with the POSH1 start codon and the Kozak consensus
sequence (bottom row). ATG codons are indicated in bold. (Panel C) HEK293T cells were transfected with either POSH2 (AA1–70)-GFP (ATG1+2), POSH2 (AA46–70)-GFP
(ATG2) or plain GFP. Western blot analysis of cell lysates using an anti-GFP antibody is shown. Mobility of the different proteins and molecular weight markers (kDa) are
indicated.
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Fig. 2. POSH2 self ubiquitination depends on the RING ﬁnger domain. HEK293T
cells were transfected with Flag-tagged wild type or RING ﬁnger mutant (CH-AA)
POSH1 and POSH2 with co-transfected Ubi-HA when indicated. Part of the cell
lysates was used for Western blot analysis of the expression of POSH using the anti-
Flag antibody (lower panel) the remaining was immunoprecipitated using anti-Flag
followed by anti-HA Western blotting to detect ubiquitinated POSH (upper panel).
Arrow heads indicate the different ubiquitinated forms of POSH. Molecular weight
markers are indicated (kDa).
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Concomitantly, the protein expression levels of both the wild type
POSH1 and POSH2, as seen in the anti-Flag blot, were decreased.
The small amounts of remaining POSH protein, however were
found to be massively ubiquitinated (upper panel). Mutation of
C73 and H75 for POSH2 and C28 and H30 for POSH1 into alanine
residues (CH-AA mutants) resulted in marked reduction of the le-
vel of ubiquitination for both POSH1 and POSH2 indicating that
these residues in POSH2 are indeed involved in self-ubiquitination
of the protein. The transfected protein levels of the mutant POSHs
in the Ubi-HA co-transfection was improved as well as the trans-
fection/survival efﬁciency, especially in the case of POSH1 but also
for POSH2.
In the absence of the Ubi-HA we did not see consistent differ-
ences in the protein amounts between the wild type and RING mu-
tants of both POSHs. This is in disagreement with result publishedby Xu et al. [13] who found decreased protein levels of the wild
type POSH1 in the absence of a construct that enhances ubiquitina-
tion. We have at the moment no explanation for these differences,
but speculate that there are differences in the self-ubiquitination
and subsequent stability of POSH in the different experiments,
although the same cell line was used.
From this experiment we concluded that POSH2 indeed con-
tains a functional RING ﬁnger domain that transfers E3 ligase activ-
ity to this protein.
3.4. The POSH2 RBD consists of a partial CRIB domain
POSH1 was originally identiﬁed as a Rac GTPase binding inter-
acting protein from a yeast 2-hybrid screen using L61 Rac as bait
[11]. POSH1 did not bind to Rho and Cdc42 and only bound Rac
when it was loaded with GTP. Tapon et al. determined that the
minimal Rac binding domain (RBD) of POSH1 was a region of 70
amino acids (AA292–362). The authors did not ﬁnd sequence
homologies with other GTPase binding proteins and therefore
named it a unique GTPase binding site. We performed GTPase
overlay experiments to determine whether this region in POSH2
also contains GTPase binding activity. As shown in Fig. 3A, GST-
POSH2 (AA369–439) bound GTP-loaded Rac1 comparable to GST-
POSH1 (AA292–362). The POSH2 domain bound in a GTP-depen-
dent manner and was speciﬁc for Rac1 since no binding to GDP-
loaded Rac1 and GTP-loaded Cdc42 was detected. Although our
detection limit does not allow to conclude the absence of an inter-
action with the GDP-loaded Rac1 the difference with the GTP-
loaded GTPase is obvious and in line with results obtained with
the POSH1 fragment [11].
From our alignment of POSH1, 2, and 3 we noted that the region
responsible for Rac binding is highly conserved. In fact, part of the
region shows similarity with part of the CRIB (Cdc42- and Rac-
interactive binding) domain with the consensus sequence I-S-X-
P-(X)2–4-F-X-H-X-X-H-V-G [19]. In Fig. 3B we aligned the CRIB do-
mains of proteins known to interact with either Cdc42 or Rac [19]
with the sequences of POSH. The Rac interacting region in POSH
contained the N-terminal I-S-X-P sequence of the CRIB domain.
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Fig. 3. The partial CRIB domain of POSH2 is required for Rac1 binding. (A) GST (negative control, spot1), GST-PAK2N (positive control, spot 2), GST-POSH1 (AA292–362) (spot
3), and GST-POSH2 (AA369–439) were spotted on nitrocellulose and incubated with either GTP- or GDP-loaded Cdc42 or Rac1 as indicated. Protein quantity and quality has
been determined by protein measurement as well as SDS–PAGE. (B) Alignment of proteins containing the CRIB domain that have known Rac or Cdc42 binding activity (taken
from [19]), complemented with the comparable region in human POSH1–3 and POSH from Drosophila melanogaster. (C) HEK293T cells were co-transfected with myc-tagged
Rac1V12 and different POSH2 (AA369–439) wild type and mutant GST fusion constructs. The ISP mutant has all three amino acids are mutated; I403N, S404P, and P406A. The
I403N and S404P have single amino acid changes. L385A and P414 are control mutations of conserved amino acids that are on either side of the I-S-X-P motif. Rac1V12 was
immunoprecipitated, using anti-Myc, from the cell lysates and the bound POSH2 fragments were analysed by Western blot detection using anti-GST (upper panel). Intensity
of the signal was quantiﬁed and expressed as percentage of binding as compared to the wild type fragment. Part of the pull down beads was used to control for the presence of
Rac1 (lower panel) and part of the lysates was used to determine the amounts of the POSH2 fragments (middle panel). Molecular weight markers are indicated (kDa) (IgG-L is
immunoglobulin light chain). (D) JNK activation was measured through an AP-1-luciferase reporter assays in cells transfected with either full length wild type (WT), or S404P
mutant POSH2, or without POSH2 (BG). Standard error is indicated.
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p21-activated kinase has been shown to disrupt its interaction
with Cdc42 [20]. We therefore generated mutant forms of POSH2
(AA369–439) in which several of these potentially critical amino
acids were mutated either alone (I403N and S404P) or combined
(I403N/S404P/P406A (ISP)) as well as control mutations L385A
and P414 that are conserved amino acids located on either side
of the I-S-X-P motif. Because the signal from our GTPase overlay
experiments was rather poor we used a different experimental set-
up in the mutation analysis. The GTPase interaction was studied by
pull down of the POSH GST-fusion proteins by co-transfected dom-
inantly GTP-loaded Myc-tagged Rac (Fig. 3C).
From our experiment it was clear that the I-S-X-P part of the
CRIB domain is critical for Rac binding. The amounts of Rac1 pro-
tein present on the immunoprecipitation beads were, unfortu-
nately, not identical in all the different samples (Fig. 3C, lower
panel). However, the decreased amounts of co-precipitated ISP,
I403N, or S404P mutant POSH2 (AA369–439) compared to the wild
type fragment can not be explained by reduced amounts of Rac1,
since in these samples the Rac1 levels were higher then in the wild
type.3.5. Perturbation of the partial CRIB domain affects JNK activation by
POSH2
POSH1 acts as a scaffold for a multiprotein complex that trans-
duces signals from GTP-loaded Rac1 to JNK activation [11,13,21].
Potentially POSH2 would function in a similar way and the antici-
pated JNK activation should then be perturbed by mutation of the
partial CRIB domain. To measure JNK activation we used a lucifer-
ase reporter construct consisting of 3 binding sites for the AP-1
transcription factor that drives the expression of luciferase. As
shown in Fig. 3D, transfection of wild type POSH2 greatly increased
the luciferase expression as compared with the control transfec-
tion without POSH2 (BG) indicating that this assay indeed func-
tions as intended.
We generated one of the mutations of the partial CRIB domain
(S404P) in the full length POSH2 protein and compared this mutant
construct to the wild type protein. Although not very large, the dif-
ference between the wild type and mutant construct was signiﬁ-
cant (P < 0.01) indicating that the Rac1 binding through the
partial CRIB domain is functionally comparable to the traditional
interaction between GTPase and CRIB domain.
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CRIB domain; the partition-defective protein Par6. Par6 was ﬁrst
identiﬁed from the nematode Caenorhabditis elegans but subse-
quently also found in mammals. It is essential for asymmetric cell
division and polarized growth and contains a ‘semi-CRIB’ motif
which is necessary, but not sufﬁcient, for binding to Cdc42 and
TC10, but not with Rac [22]. The semi-CRIB domain of Par6 (I-S-
X-P-X-X-F) [23] consists of a slightly larger part of the CRIB domain
then the part we identiﬁed in POSH2. In both proteins the C-termi-
nal part of the CRIB domain with the two invariant histidine resi-
dues is missing. From the crystal structure of Cdc42 with Par6 it
has become apparent that a bordering PDZ (PSD95/Discs Large/
ZO-1) domain is essential for this interaction. The PDZ domain
and the semi-CRIB domain form a continuous structure in which
the PDZ domain acts as a structural scaffold for the semi-CRIB do-
main [23]. In POSH there is no adjacent PDZ domain and it will
therefore be of interest to study the possible involvement of other
regions of the POSH protein in the interaction with Rac. It is rele-
vant to note in this respect that a major phosphorylation site of
Akt in POSH1 is Serine 304 which lies about 22 amino acids C-ter-
minal of the I-S-X-P sequence in the RBD domain. Phosphorylation
of this residue was found to decrease the ability of POSH1 to bind
Rac [24].
The possible interaction between POSH3 and Rac has not been
documented so far. The I-S-X-P sequence is also present in this pro-
tein and also the sequence immediately C-terminal is conserved.
However the overall sequence homology of POSH3 with POSH1
and POSH2 is not high throughout the RBD fragment. Surprisingly,
D. melanogaster DPOSH has been found not to bind to Rac [25]
(data presented as ‘not shown’ in this paper), although the partial
CRIB domain is very well conserved according to our alignment.
Currently there is no explanation for this, other than a possible lack
of sensitivity of the performed assay. The downstream effect of the
interaction between POSH1 and Rac is activation of the JNK/SAPK
pathway [11,13,24]. This downstream effect is conserved also in
Drosophila [25] suggesting a possible involvement of and interac-
tion with Rac.
In conclusion, POSH2 is a ubiquitously expressed E3 ligase of
the mammalian family of POSH proteins which has now three
members. POSH2 can interact with GTP-loaded Rac using only a
partial CRIB domain.
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